SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Gene therapies for BCG-unresponsive bladder cancer have high response rates.

2.

Males with early-onset colorectal cancer are at risk, according to a study.

3.

Study reveals crucial gaps in oral cancer awareness in Middle East and North Africa

4.

For incarcerated people, study shows gaps exist in quality of cancer care

5.

Whole Foods Recall; RFK Jr.'s Voting Problem; Glass Particles in Biosimilar


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot